Skip to content

Opening book details…

About this Medicine article

Pangenotypic therapies glecaprevir-pibrentasvir (G-P) and sofosbuvir-velpatasvir-voxilaprevir (S-V-V) after failure with interferon (IFN)-free direct-acting antiviral (DAA) treatment for hepatitis C by Flamm, Steven; Tsai, Naoky; Bacon, Bruce; Curry, Michael; Milligan, Scott; Wick, Nicole; Younossi, Zobair; Afdhal, Nezam is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Flamm, Steven; Tsai, Naoky; Bacon, Bruce; Curry, Michael; Milligan, Scott; Wick, Nicole; Younossi, Zobair; Afdhal, Nezam
Publisher
Elsevier Science; Elsevier ; Elsevier BV; Wiley (ISSN 0168-8278)
Published
2020
Field
Medicine (Health Sciences)

More by Flamm, Steven; Tsai, Naoky; Bacon, Bruce; Curry, Michael; Milligan, Scott; Wick, Nicole; Younossi, Zobair; Afdhal, Nezam

Browse all works by Flamm, Steven; Tsai, Naoky; Bacon, Bruce; Curry, Michael; Milligan, Scott; Wick, Nicole; Younossi, Zobair; Afdhal, Nezam